TBAuctions has acquired British Medical Auctions to expand its online auction platform in the medical equipment market across Europe.
Information on the Target
British Medical Auctions (BMA) specializes in the online auctioning of surplus medical equipment from the healthcare sector. The company conducts weekly and monthly live and timed online auctions, catering to a global audience of buyers, primarily hospitals, health institutions, real estate agents, and financial institutions. BMA offers a diverse range of medical equipment such as surgical tools, dialysis systems, radiology equipment, respiratory devices, and endoscopy instruments. In addition to auction services, BMA also provides comprehensive solutions including equipment valuations, certified data erasure, liability management, de-installation services, and on-site collection.
With a customer base exceeding 10,000 registered online buyers worldwide, BMA operates from the United Kingdom and France, contributing significantly to enhancing the diversity and availability of medical equipment within the healthcare market. Its experience of over 20 years in the auction industry positions it as an established player known for its specialization in medical auctions.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the UK
The online auction market in the UK has been experiencing notable growth, driven by the increasing shift towards digitalization across various sectors. The pandemic has accelerated the need for efficient online platforms, particularly in fields such as healthcare, whe
Similar Deals
Aya Healthcare → Locum’s Nest
2025
Foresight Group → MyWay Digital Health Ltd
2025
Keensight Capital → Bedfont Scientific
2025
Telemos Capital → Helios
2024
Calibre Scientific → Greyhound Chromatography and Allied Chemicals Ltd.
2024
TBAuctions
invested in
British Medical Auctions
in 2022
in a Other Private Equity deal